pyrazolo(3,4-d)pyrimidine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biava, M; Botta, M; Brullo, C; Carraro, F; Crespan, E; Esté, JA; Falchi, F; Kissova, M; La Rocca, F; Laurenzana, I; Maga, G; Ruiz, A; Schenone, S; Tintori, C | 1 |
1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents.
Topics: Anti-HIV Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Design; HIV Infections; HIV-1; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-hck; Pyrazoles; Pyrimidines; Virus Replication | 2013 |